John Newman

John Newman

Total lobbying returns involving this official: 20

Connections GraphMethod Pie

Official Profile

Most Recent Title
Assistant Secretary
Most Recent Public Body
Department of Business, Enterprise and Innovation
First Seen
14 September 2020
Last Seen
21 May 2025

Observed Titles

Assistant Secretary

Observed Public Bodies

Department of Business, Enterprise and InnovationDepartment of Enterprise, Trade and Employment
All Lobbyists
Select methods...

Lobbying Records (Page 1 of 2)

Current/Former DPOFAQ

Intent: To support the competitiveness of the pharmaceutical industry in Europe and not therefore dilute or reduce RDP.::To include medical devices in Regulatory Sandboxes. ::Government to take strategic, integrated approach to address pharmaceutical industry concerns across diverse areas.

Details: EU Commission proposed revision of the EU General Pharmaceutical Legislation and related matters, with particular attention to intellectual property rights provisions, competitiveness and regulatory affairs.

Methods
EmailMeeting
Current/Former DPOFAQ

Intent: Consider the implications of the unfair distribution of the costs on the pharmaceutical industry for the quaternary treatment of waste water. ::Take account of industry concerns at flawed cost allocation for quaternary treatment of urban waste water solely to pharmaceutical and cosmetic sectors in Directive. ::Request Irish Government to take strategic, integrated approach to address pharmaceutical industry concerns across diverse areas.::Minister for Housing to share with other EU Member States' expressed concern at disproportionate and unfair allocation of cost for quaternary treatment of urban waste water solely to pharmaceutical and cosmetics sectors in Directive.

Details: European Commission Urban Waste Water Treatment Directive (UWWTD), with particular attention to the polluter payers principal and proportional responsibility.

Methods
EmailInformal communicationMeeting
Current/Former DPOFAQ

Intent: (i) Ireland to adopt a position at European Council that would not cut Regulatory Data Protection; (ii) Take account of industry initiatives on improving access.

Details: (i) Proposed revision of EU General Pharmaceutical Legislation, particularly items relating to incentives/intellectual property rights; (ii) EU wide access to new medicines.

Methods
EmailLetterMeeting

Intent: Tax reform package, housing and infrstructure development, securing a green economy, productivity development, indigenous industrial policy reform, establishing a state security clearance regime, maintaining the public sector, protecting the social welfare system, credible state risk assessment and control.

Details: ISME Pre Budget Submission 2024

Methods
Email

Ibec

2023-01-21

Intent: Ensure procedures are fair, transparent, proportionate, consistent with Irish legal system and with wider civil justice reforms.

Details: Representative Actions for the Protection of the Collective Interests of Consumers Bill 2022

Officials
Methods
Email